Literature DB >> 9712701

A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils.

P I Chuang1, E Yee, A Karsan, R K Winn, J M Harlan.   

Abstract

During the process of terminal differentiation toward mature neutrophils, the anti-apoptotic proteins Bcl-2 and Bcl-x become down-regulated and eventually cease to be expressed, whereas the death-promoting Bcl-2 homologue, Bax, persists. Thus, the disappearance of anti-apoptotic homologues was thought to account for the early demise of mature neutrophils. However, although the survival of mature human neutrophils can be prolonged by a variety of factors, no anti-apoptotic Bcl-2 homologues have previously been identified. Human A1 is a Bcl-2 homologue previously shown to be present in endothelial cells and to convey anti-apoptotic function in vitro. We describe here that human A1 mRNA is constitutively expressed in mature neutrophils and is up-regulated by G-CSF and LPS, agonists that promote neutrophil survival. In addition, we show progressive A1 mRNA accumulation in HL-60 cells during all-trans retinoic acid-driven neutrophilic differentiation. Our findings suggest that A1 may have an important role in neutrophilic development and in modulating mature neutrophil survival. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712701     DOI: 10.1006/bbrc.1998.9155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 2.  Colony-stimulating factors for the management of neutropenia in cancer patients.

Authors:  David C Dale
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members.

Authors:  Tobi Higo; Vince Duronio; Christopher Tudan; Helen M Burt; John K Jackson
Journal:  Inflamm Res       Date:  2009-08-08       Impact factor: 4.575

4.  Delayed apoptosis of circulating neutrophils in Kawasaki disease.

Authors:  H Tsujimoto; S Takeshita; K Nakatani; Y Kawamura; T Tokutomi; I Sekine
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

5.  Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3.

Authors:  Bram J van Raam; Agata Drewniak; Vincent Groenewold; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

6.  Antiapoptotic effect of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and cyclic AMP on human neutrophils: protein synthesis-dependent and protein synthesis-independent mechanisms and the role of the Janus kinase-STAT pathway.

Authors:  Chikahiko Sakamoto; Kenichi Suzuki; Fumihiko Hato; Mika Akahori; Taro Hasegawa; Masayuki Hino; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

7.  Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.

Authors:  Scott Boiko; Theresa Proia; Maryann San Martin; Gareth P Gregory; Michelle Min Wu; Neeraj Aryal; Maureen Hattersley; Wenlin Shao; Jamal C Saeh; Stephen E Fawell; Ricky W Johnstone; Lisa Drew; Justin Cidado
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

Review 8.  A1/Bfl-1 in leukocyte development and cell death.

Authors:  Eleonora Ottina; Denise Tischner; Marco J Herold; Andreas Villunger
Journal:  Exp Cell Res       Date:  2012-02-04       Impact factor: 3.905

Review 9.  Neutrophil apoptosis and the resolution of infection.

Authors:  Adam D Kennedy; Frank R DeLeo
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

10.  Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis.

Authors:  Mohamed Abdgawad; Åsa Pettersson; Lena Gunnarsson; Anders A Bengtsson; Pierre Geborek; Lars Nilsson; Mårten Segelmark; Thomas Hellmark
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.